Hi y'all
I guess that the most informative part of the PR to me was the need for additional studies in P. In my twisted mind I had conjured up the idea that the reason the poc didn't go forward was because eu regulatory authorities had not approved or wanted additional information about the drugs actions.
This confirms that for me.
Now its only my opinion so everybody don't get your panties in a twist but what else makes sense??
I guess that the most informative part of the PR to me was the need for additional studies in P. In my twisted mind I had conjured up the idea that the reason the poc didn't go forward was because eu regulatory authorities had not approved or wanted additional information about the drugs actions.
This confirms that for me.
Now its only my opinion so everybody don't get your panties in a twist but what else makes sense??